Skip to main content
. Author manuscript; available in PMC: 2025 Jun 1.
Published in final edited form as: Pediatr Infect Dis J. 2024 Feb 12;43(6):520–524. doi: 10.1097/INF.0000000000004278

Figure 1.

Figure 1.

(A) Scatter plots demonstrating the correlation of age with TDD of CIV divided by body weight (mg/kg/day) and (C) body surface area (mg/m2/day) in courses that achieved a therapeutic steady-state concentration. Linear regression lines (solid blue) have been fitted to the data points. (B) Boxplots comparing the TDD of CIV divided by body weight (mg/kg/day) and (D) body surface area (mg/m2/day) between two age-based cohorts in courses that achieved a therapeutic steady-state concentration. The top and bottom of the boxplots show the 25th and 75th percentile and the dark band shows the median. The dots represent outliers. CIV = continuous infusion vancomycin; TDD = total daily dose